Great Point Partners as of March 31, 2016
Portfolio Holdings for Great Point Partners
Great Point Partners holds 32 positions in its portfolio as reported in the March 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Adamas Pharmaceuticals | 10.9 | $31M | 2.1M | 14.46 | |
Five Prime Therapeutics | 8.4 | $23M | 575k | 40.63 | |
Vanda Pharmaceuticals (VNDA) | 8.2 | $23M | 2.7M | 8.36 | |
Zogenix | 6.9 | $19M | 2.1M | 9.24 | |
Tetraphase Pharmaceuticals | 6.1 | $17M | 3.7M | 4.63 | |
Bluebird Bio (BLUE) | 6.0 | $17M | 393k | 42.50 | |
Exelixis (EXEL) | 5.6 | $16M | 3.9M | 4.00 | |
Neurocrine Biosciences (NBIX) | 4.6 | $13M | 325k | 39.55 | |
Intercept Pharmaceuticals In | 4.6 | $13M | 100k | 128.47 | |
Vericel (VCEL) | 4.4 | $12M | 2.1M | 5.86 | |
Connecture | 3.8 | $11M | 4.1M | 2.56 | |
Alcobra | 2.8 | $7.7M | 2.0M | 3.79 | |
Aurinia Pharmaceuticals (AUPH) | 2.6 | $7.2M | 2.5M | 2.92 | |
Xencor (XNCR) | 2.5 | $7.1M | 529k | 13.42 | |
Avalanche Biotechnologies In | 2.4 | $6.7M | 1.3M | 5.17 | |
Chimerix (CMRX) | 2.4 | $6.6M | 1.3M | 5.11 | |
Raptor Pharmaceutical | 2.2 | $6.2M | 1.3M | 4.60 | |
Synergy Pharmaceuticals | 2.1 | $6.0M | 2.2M | 2.76 | |
Ocera Therapeutics | 2.1 | $5.8M | 2.0M | 2.94 | |
Paratek Pharmaceuticals | 1.7 | $4.6M | 306k | 15.17 | |
Bovie Medical Corporation | 1.6 | $4.5M | 2.7M | 1.67 | |
Sunesis Pharmaceuticals | 1.6 | $4.5M | 8.3M | 0.54 | |
Aradigm | 1.6 | $4.5M | 1.0M | 4.44 | |
Sarepta Therapeutics (SRPT) | 1.1 | $2.9M | 150k | 19.52 | |
ACADIA Pharmaceuticals (ACAD) | 1.0 | $2.8M | 100k | 27.96 | |
Tenax Therapeutics | 0.8 | $2.3M | 1.1M | 2.05 | |
Ignyta | 0.7 | $1.9M | 287k | 6.77 | |
Portola Pharmaceuticals | 0.6 | $1.6M | 79k | 20.40 | |
Caladrius Biosciences | 0.5 | $1.3M | 1.7M | 0.75 | |
Rigel Pharmaceuticals (RIGL) | 0.1 | $328k | 158k | 2.08 | |
Streamline Health Solutions (STRM) | 0.1 | $214k | 152k | 1.41 | |
Atyr Pharma Inc Common Stock Usd 0.001 | 0.1 | $197k | 50k | 3.95 |